Kos the Specialty Pharmaceutical Company is Currently Developing New Products.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c32127) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: Kos Pharmaceuticals Drug-Delivery Company Intelligence Report to their offering. Industry and commercial interest in drug delivery has been building steadily. The benefits to patients can be seen in improved compliance and medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes and bring new therapies to the market that would, previously, have been impossible. These detailed company reports bring into focus the companies which driving growth and innovation in drug delivery. Over 140 leading players are examined with details for Company Overview, Key Personnel, Key Milestones, Products/Technologies, Research Strategy, Agreements, Financial Data and Associated Companies associated company associate n → Partnerfirma f associated company n → società collegata (if any) provided for each. Topics Covered 1. Key Personnel 2. Company Overview 3. Key Milestones 4. Products/Technologies 5. Research Activities 6. Agreements 7. Key Financial Data 8. Associated Companies 9. Competition Summary Kos Pharmaceuticals Inc is a fully-integrated specialty pharmaceutical company engaged in developing, commercialising, manufacturing and marketing proprietary prescription products for the treatment of chronic diseases. The company's principal product development strategy is to reformulate Verb 1. reformulate - formulate or develop again, of an improved theory or hypothesis redevelop formulate, explicate, develop - elaborate, as of theories and hypotheses; "Could you develop the ideas in your thesis" existing pharmaceutical products to improve safety, efficacy, or patient compliance. The company currently markets Niaspan and Advicor for the treatment of cholesterol disorders and Azmacort Az·ma·cort A trademark for the drug triamcinolone acetonide. for the treatment of asthma asthma (ăz`mə, ăs`–), chronic inflammatory respiratory disease characterized by periodic attacks of wheezing, shortness of breath, and a tight feeling in the chest. A cough producing sticky mucus is symptomatic. . Kos is developing additional products and has proprietary drug-delivery technologies in solid-dose and aerosol aerosol (âr`əsōl,–sŏl): see colloid. aerosol System of tiny liquid or solid particles evenly distributed in a finely divided state through a gas, usually air. metered-dose inhalation inhalation /in·ha·la·tion/ (in?hah-la´shun) 1. the drawing of air or other substances into the lungs.inhala´tional 2. the drawing of an aerosolized drug into the lungs with the breath. 3. administration. For more information visit http://www.researchandmarkets.com/reports/c32127 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion